SMS Pharmaceuticals Limited — Updates, 26-08-2025: Press Release
26-08-2025 | 05:29 pm
26-08-2025 | 05:29 pm
SMS Pharma's Hyderabad analytical lab received a USFDA 'No Action Indicated' (NAI) Establishment Inspection Report (EIR) with zero observations. This positive outcome boosts regulatory standing, global partnerships, and future growth.
No comments yet. Be the first to comment!
